Donald E Mahan

Title: The Innovative Contributions of Donald E. Mahan

Introduction

Donald E. Mahan, based in Raleigh, North Carolina, is an esteemed inventor known for his significant contributions to the field of medical diagnostics. With two patents to his name, Mahan has developed groundbreaking methods and reagents for coagulation assays and platelet/leukocyte interaction assessments, demonstrating his impact in healthcare innovation.

Latest Patents

Mahan's latest patents include:

1. **Coagulation assay reagents containing lanthanides**: This innovation provides a method, kit, system, and reagent that enhances the sensitivity and dynamic range of coagulation assays. By utilizing metal compounds that interact with calcium binding sites in the blood coagulation cascade, particularly lanthanides, manganese, and magnesium compounds, this patent significantly improves detection capabilities in medical testing.

2. **Platelet/leukocyte interaction assay and reagent therefor**: This invention offers a reliable assay method along with reagents that use solid-phase stimuli, which may include magnetic or non-magnetic particles. By enabling interaction with platelets and leukocytes, this method provides a fast and effective point-of-care assessment leading to better clinical decisions.

Career Highlights

Donald E. Mahan is currently associated with Pharmanetics Incorporated, where he has been pivotal in advancing diagnostic technology. His work is characterized by a commitment to enhancing the accuracy and reliability of medical tests, ultimately contributing to improved patient outcomes.

Collaborations

Throughout his career, Mahan has collaborated with notable colleagues such as Michael William Stewart and Gwyn A. Cutsforth. These partnerships have facilitated the development of innovative solutions in the realm of medical diagnostics, leveraging collective expertise to push the boundaries of current technologies.

Conclusion

Donald E. Mahan exemplifies the spirit of innovation through his contributions to healthcare diagnostics. His patents not only reflect his technical acumen but also his dedication to enhancing medical testing methodologies. As he continues to work with Pharmanetics Incorporated, Mahan's influence on the industry is likely to grow, paving the way for future advancements in health technologies.